Table 1.
Clinical characteristic of 136 patients with ESCC
| Characteristics | No. (%) |
|---|---|
| Total case | 136 |
| Age (Years) | |
| Median | 62 |
| Range | 35-90 |
| Gender | |
| Male | 111 (81.6%) |
| Female | 25 (18.4%) |
| WHO degree | |
| G1 | 40 (29.4%) |
| G2 | 59 (43.4%) |
| G3 | 37 (27.2%) |
| Tumor (T) status | |
| T1 | 8 (5.9%) |
| T2 | 36 (26.5%) |
| T3 | 88 (64.7%) |
| T4 | 4 (2.9%) |
| Lymphoid Nodal (N) status | |
| N0 | 69 (50.7%) |
| N1 | 67 (49.3%) |
| Distant metastasis (M) status | |
| M0 | 130 (95.6%) |
| M1 | 6 (4.4%) |
| TNM stage | |
| I | 6 (4.4%) |
| IIa-IIb | 68 (50.0%) |
| III | 56 (41.2%) |
| IV | 6 (4.4%) |
| Death | |
| No | 33 (24.3%) |
| Yes | 103 (75.7%) |
| Therapy after surgery | |
| Radiation therapy alone | 10 (7.4%) |
| Chemotherapy alone | 12 (8.8%) |
| Radiation therapy + chemotherapy | 7 (5.1%) |
| No | 107 (78.7%) |